187 related articles for article (PubMed ID: 24362578)
1. Interaction of classical platinum agents with the monomeric and dimeric Atox1 proteins: a molecular dynamics simulation study.
Wang X; Li C; Wang Y; Chen G
Int J Mol Sci; 2013 Dec; 15(1):75-99. PubMed ID: 24362578
[TBL] [Abstract][Full Text] [Related]
2. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
[TBL] [Abstract][Full Text] [Related]
4. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
[TBL] [Abstract][Full Text] [Related]
5. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
Xi Z; Guo W; Tian C; Wang F; Liu Y
Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
[TBL] [Abstract][Full Text] [Related]
6. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
10. The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics.
Yu CH; Yang N; Bothe J; Tonelli M; Nokhrin S; Dolgova NV; Braiterman L; Lutsenko S; Dmitriev OY
J Biol Chem; 2017 Nov; 292(44):18169-18177. PubMed ID: 28900031
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
[TBL] [Abstract][Full Text] [Related]
12. Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study.
Perkal O; Qasem Z; Turgeman M; Schwartz R; Gevorkyan-Airapetov L; Pavlin M; Magistrato A; Major DT; Ruthstein S
J Phys Chem B; 2020 Jun; 124(22):4399-4411. PubMed ID: 32396355
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
[TBL] [Abstract][Full Text] [Related]
14. Unraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach.
Fortino M; Arnesano F; Pietropaolo A
J Phys Chem B; 2024 Jun; 128(22):5336-5343. PubMed ID: 38780400
[TBL] [Abstract][Full Text] [Related]
15. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
16. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
[TBL] [Abstract][Full Text] [Related]
17. Conserved residue modulates copper-binding properties through structural dynamics in human copper chaperone Atox1.
Xi Z; Shi C; Tian C; Liu Y
Metallomics; 2013 Nov; 5(11):1566-73. PubMed ID: 24056613
[TBL] [Abstract][Full Text] [Related]
18. Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
Öhrvik H; Wittung-Stafshede P
Int J Mol Sci; 2015 Jul; 16(8):16728-39. PubMed ID: 26213915
[TBL] [Abstract][Full Text] [Related]
19. Copper coordination states affect the flexibility of copper Metallochaperone Atox1: Insights from molecular dynamics simulations.
Schwartz R; Ruthstein S; Major DT
Protein Sci; 2022 Dec; 31(12):e4464. PubMed ID: 36208051
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of cisplatin bound to a human copper chaperone.
Boal AK; Rosenzweig AC
J Am Chem Soc; 2009 Oct; 131(40):14196-7. PubMed ID: 19807176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
